Cargando…
Palliative Senning in the Treatment of Congenital Heart Disease with Severe Pulmonary Hypertension
BACKGROUND: Transposition of the great arteries (TGA) is the most common cyanotic cardiopathy, with an incidence ranging between 0.2 and 0.4 per 1000 live births. Many patients not treated in the first few months of life may progress with severe pulmonary vascular disease. Treatment of these patient...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632999/ https://www.ncbi.nlm.nih.gov/pubmed/26559982 http://dx.doi.org/10.5935/abc.20150097 |
_version_ | 1782399131885502464 |
---|---|
author | da Penha, Juliano Gomes Zorzanelli, Leina Barbosa-Lopes, Antonio Augusto Atik, Edimar Miana, Leonardo Augusto Tanamati, Carla Caneo, Luiz Fernando Miura, Nana Aiello, Vera Demarchi Jatene, Marcelo Biscegli |
author_facet | da Penha, Juliano Gomes Zorzanelli, Leina Barbosa-Lopes, Antonio Augusto Atik, Edimar Miana, Leonardo Augusto Tanamati, Carla Caneo, Luiz Fernando Miura, Nana Aiello, Vera Demarchi Jatene, Marcelo Biscegli |
author_sort | da Penha, Juliano Gomes |
collection | PubMed |
description | BACKGROUND: Transposition of the great arteries (TGA) is the most common cyanotic cardiopathy, with an incidence ranging between 0.2 and 0.4 per 1000 live births. Many patients not treated in the first few months of life may progress with severe pulmonary vascular disease. Treatment of these patients may include palliative surgery to redirect the flow at the atrial level. OBJECTIVE: Report our institutional experience with the palliative Senning procedure in children diagnosed with TGA and double outlet right ventricle with severe pulmonary vascular disease, and to evaluate the early and late clinical progression of the palliative Senning procedure. METHODS: Retrospective study based on the evaluation of medical records in the period of 1991 to 2014. Only patients without an indication for definitive surgical treatment of the cardiopathy due to elevated pulmonary pressure were included. RESULTS: After one year of follow-up there was a mean increase in arterial oxygen saturation from 62.1% to 92.5% and a mean decrease in hematocrit from 49.4% to 36.3%. Lung histological analysis was feasible in 16 patients. In 8 patients, pulmonary biopsy grades 3 and 4 were evidenced. CONCLUSION: The palliative Senning procedure improved arterial oxygen saturation, reduced polycythemia, and provided a better quality of life for patients with TGA with ventricular septal defect, severe pulmonary hypertension, and poor prognosis. |
format | Online Article Text |
id | pubmed-4632999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Sociedade Brasileira de Cardiologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-46329992015-11-05 Palliative Senning in the Treatment of Congenital Heart Disease with Severe Pulmonary Hypertension da Penha, Juliano Gomes Zorzanelli, Leina Barbosa-Lopes, Antonio Augusto Atik, Edimar Miana, Leonardo Augusto Tanamati, Carla Caneo, Luiz Fernando Miura, Nana Aiello, Vera Demarchi Jatene, Marcelo Biscegli Arq Bras Cardiol Original Articles BACKGROUND: Transposition of the great arteries (TGA) is the most common cyanotic cardiopathy, with an incidence ranging between 0.2 and 0.4 per 1000 live births. Many patients not treated in the first few months of life may progress with severe pulmonary vascular disease. Treatment of these patients may include palliative surgery to redirect the flow at the atrial level. OBJECTIVE: Report our institutional experience with the palliative Senning procedure in children diagnosed with TGA and double outlet right ventricle with severe pulmonary vascular disease, and to evaluate the early and late clinical progression of the palliative Senning procedure. METHODS: Retrospective study based on the evaluation of medical records in the period of 1991 to 2014. Only patients without an indication for definitive surgical treatment of the cardiopathy due to elevated pulmonary pressure were included. RESULTS: After one year of follow-up there was a mean increase in arterial oxygen saturation from 62.1% to 92.5% and a mean decrease in hematocrit from 49.4% to 36.3%. Lung histological analysis was feasible in 16 patients. In 8 patients, pulmonary biopsy grades 3 and 4 were evidenced. CONCLUSION: The palliative Senning procedure improved arterial oxygen saturation, reduced polycythemia, and provided a better quality of life for patients with TGA with ventricular septal defect, severe pulmonary hypertension, and poor prognosis. Sociedade Brasileira de Cardiologia 2015-10 /pmc/articles/PMC4632999/ /pubmed/26559982 http://dx.doi.org/10.5935/abc.20150097 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles da Penha, Juliano Gomes Zorzanelli, Leina Barbosa-Lopes, Antonio Augusto Atik, Edimar Miana, Leonardo Augusto Tanamati, Carla Caneo, Luiz Fernando Miura, Nana Aiello, Vera Demarchi Jatene, Marcelo Biscegli Palliative Senning in the Treatment of Congenital Heart Disease with Severe Pulmonary Hypertension |
title | Palliative Senning in the Treatment of Congenital Heart Disease with
Severe Pulmonary Hypertension |
title_full | Palliative Senning in the Treatment of Congenital Heart Disease with
Severe Pulmonary Hypertension |
title_fullStr | Palliative Senning in the Treatment of Congenital Heart Disease with
Severe Pulmonary Hypertension |
title_full_unstemmed | Palliative Senning in the Treatment of Congenital Heart Disease with
Severe Pulmonary Hypertension |
title_short | Palliative Senning in the Treatment of Congenital Heart Disease with
Severe Pulmonary Hypertension |
title_sort | palliative senning in the treatment of congenital heart disease with
severe pulmonary hypertension |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632999/ https://www.ncbi.nlm.nih.gov/pubmed/26559982 http://dx.doi.org/10.5935/abc.20150097 |
work_keys_str_mv | AT dapenhajulianogomes palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT zorzanellileina palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT barbosalopesantonioaugusto palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT atikedimar palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT mianaleonardoaugusto palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT tanamaticarla palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT caneoluizfernando palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT miuranana palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT aielloverademarchi palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension AT jatenemarcelobiscegli palliativesenninginthetreatmentofcongenitalheartdiseasewithseverepulmonaryhypertension |